Tue, July 17, 2018
Mon, July 16, 2018
Fri, July 13, 2018
Thu, July 12, 2018
Wed, July 11, 2018
Tue, July 10, 2018
Mon, July 9, 2018
Fri, July 6, 2018
Thu, July 5, 2018
Tue, July 3, 2018
Mon, July 2, 2018
Fri, June 29, 2018
Thu, June 28, 2018
Wed, June 27, 2018
Tue, June 26, 2018
Mon, June 25, 2018
Fri, June 22, 2018
Thu, June 21, 2018
Wed, June 20, 2018

Robyn Karnauskas Upgraded (BIIB) to Strong Buy and Held Target at $371 on, Jul 6th, 2018


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-371-on-jul-6th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Robyn Karnauskas of Citigroup, Upgraded "Biogen Inc." (BIIB) to Strong Buy and Held Target at $371 on, Jul 6th, 2018.

Robyn has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Thursday, April 5th, 2018


These are the ratings of the 3 analyists that currently disagree with Robyn


  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy on, Thursday, May 31st, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $369 on, Wednesday, April 25th, 2018
  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, April 25th, 2018

Publication Contributing Sources